Piperazine

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 309 Experts worldwide ranked by ideXlab platform

Henk Timmerman - One of the best experts on this subject based on the ideXlab platform.

  • Non-imidazole histamine H3 ligands. Part III. New 4-n-propylPiperazines as non-imidazole histamine H3-antagonists.
    European journal of medicinal chemistry, 2005
    Co-Authors: Krzysztof Walczyński, Obbe P. Zuiderveld, Henk Timmerman
    Abstract:

    In search for a new lead of non-imidazole histamine H3-receptor antagonists, a series of 1[(2-thiazolopyridine)-4-n-propyl]Piperazines, the analogous 1-[(2-oxazolopyridine)-4-npropyl]Piperazines, 1-[(2-benzothiazole)-4-n-propyl]Piperazine and 1-[(2-benzooxazole)4-n-propyl]Piperazine were prepared and in vitro tested as H3-receptor antagonists (the electrically evoked contraction of the guinea-pig jejunum). It appeared that by comparison of homologous pairs the thiazolo derivatives have slightly higher activity than their oxazolo analogues. The most potent compound of these series is the 1-(2-thiazolo[4,5-c]pyridine)-4-n-propylPiperazine (3c) with pA2 = 7.25 (its oxazole analogue (4g) showed pA2 = 6.9). The structure–activity relationships for compounds with various positions of the nitrogen in the benzene ring for the thiazoles compared with oxazoles are discussed. © 2004 Elsevier SAS. All rights reserved.

Glidewell Christopher - One of the best experts on this subject based on the ideXlab platform.

  • Six 1-halo­benzoyl-4-(2-meth­­oxy­phen­yl)Piperazines having Z′ values of one, two or four; disorder, pseudosymmetry, twinning and supra­molecular assembly in one, two or three dimensions
    'International Union of Crystallography (IUCr)', 2021
    Co-Authors: Harish Chinthal Chayanna, Yathirajan H. S., Foro Sabine, Kavitha, Channappa N., Glidewell Christopher
    Abstract:

    Six 1-halobenzoyl-4-(2-meth­oxy­phen­yl)Piperazines have been prepared using carbodi­imide-mediated coupling reactions between halo­benzoic acids and N-(2-meth­oxy­phen­yl)Piperazine. The mol­ecules of 1-(4-fluoro­benzo­yl)-4-(2-meth­oxy­phen­yl)Piperazine, C18H19FN2O2 (I), are linked into a chain of rings by a combination of C—H⋯O and C—H⋯π(arene) hydrogen bonds. 1-(4-Chloro­benzo­yl)-4-(2-meth­oxy­phen­yl)Piperazine, C18H19ClN2O2 (II), crystallizes in the space group Pca21 with Z′ = 4 and it exhibits both pseudosymmetry and inversion twinning: a combination of six C—H⋯O and two C—H⋯π(arene) hydrogen bonds generate a three-dimensional assembly. In 1-(4-bromo­benzo­yl)-4-(2-meth­oxy­phen­yl)Piperazine, C18H19BrN2O2 (III), which also crystallizes in space group Pca21 but with Z′ = 2, the bromo­benzoyl unit in one of the mol­ecules is disordered. Pseudosymmetry and inversion twinning are again present, and a combination of three C—H⋯O and one C—H⋯π(arene) hydrogen bonds generate a two-dimensional assembly. A single C—H⋯O hydrogen bond links the mol­ecules of 1-(4-iodo­benzo­yl)-4-(2-meth­oxy­phen­yl)Piperazine, C18H19IN2O2 (IV), into simple chains but in the isomeric 3-iodo­benzoyl analogue (V), which crystallizes in space group P212121 with Z′ = 2, a two-dimensional assembly is generated by a combination of four C—H⋯O and two C—H⋯π(arene) hydrogen bonds; pseudosymmetry and inversion twinning are again present. A single C—H⋯O hydrogen bond links the mol­ecules of 1-(2-fluoro­benzo­yl)-4-(2-meth­oxy­phen­yl)Piperazine, C18H19FN2O2 (VI), into simple chains. Comparisons are made with the structures of some related compounds

  • Six 1-aroyl-4-(4-meth­­oxy­phen­yl)Piperazines: similar mol­ecular structures but different patterns of supra­molecular assembly
    'International Union of Crystallography (IUCr)', 2019
    Co-Authors: Kiran Kumar H., Yathirajan H. S., Sagar B. K., Foro Sabine, Glidewell Christopher
    Abstract:

    Six new 1-aroyl-4-(4-meth­oxy­phen­yl)Piperazines have been prepared, using coupling reactions between benzoic acids and N-(4-meth­oxy­phen­yl)Piperazine. There are no significant hydrogen bonds in the structure of 1-benzoyl-4-(4-meth­oxy­phen­yl)Piperazine, C18H20N2O2, (I). The mol­ecules of 1-(2-fluoro­benzo­yl)-4-(4-meth­oxy­phen­yl)Piperazine, C18H19FN2O2, (II), are linked by two C—H⋯O hydrogen bonds to form chains of rings, which are linked into sheets by an aromatic π–π stacking inter­action. 1-(2-Chloro­benzo­yl)-4-(4-meth­oxy­phen­yl)Piperazine, C18H19ClN2O2, (III), 1-(2-bromo­benzo­yl)-4-(4-meth­oxy­phen­yl)Piperazine, C18H19BrN2O2, (IV), and 1-(2-iodo­benzo­yl)-4-(4-meth­oxyphen­yl)Piperazine, C18H19IN2O2, (V), are isomorphous, but in (III) the aroyl ring is disordered over two sets of atomic sites having occupancies of 0.942 (2) and 0.058 (2). In each of (III)–(V), a combination of two C—H⋯π(arene) hydrogen bonds links the mol­ecules into sheets. A single O—H⋯O hydrogen bond links the mol­ecules of 1-(2-hy­droxy­benzo­yl)-4-(4-meth­oxy­phen­yl)Piperazine, C18H20N2O3, (VI), into simple chains. Comparisons are made with the structures of some related compounds

  • Six 1-aroyl-4-(4-methoxyphenyl)Piperazines : similar molecular structures but different patterns of supramolecular assembly
    'International Union of Crystallography (IUCr)', 2019
    Co-Authors: Kiran Kumar Haruvegowda, Yathirajan H. S., Sagar B. K., Foro Sabine, Glidewell Christopher
    Abstract:

    HSY thanks the University Grants Commission, New Delhi, for the award of a BSR Faculty Fellowship for three years.Six new 1-aroyl-4-(4-meth­oxy­phen­yl)Piperazines have been prepared, using coupling reactions between benzoic acids and N-(4-meth­oxy­phen­yl)Piperazine. There are no significant hydrogen bonds in the structure of 1-benzoyl-4-(4-meth­oxy­phen­yl)Piperazine, C18H20N2O2, (I). The mol­ecules of 1-(2-fluoro­benzo­yl)-4-(4-meth­oxy­phen­yl)Piperazine, C18H19FN2O2, (II), are linked by two C—H⋯O hydrogen bonds to form chains of rings, which are linked into sheets by an aromatic π–π stacking inter­action. 1-(2-Chloro­benzo­yl)-4-(4-meth­oxy­phen­yl)Piperazine, C18H19ClN2O2, (III), 1-(2-bromo­benzo­yl)-4-(4-meth­oxy­phen­yl)Piperazine, C18H19BrN2O2, (IV), and 1-(2-iodo­benzo­yl)-4-(4-meth­oxyphen­yl)Piperazine, C18H19IN2O2, (V), are isomorphous, but in (III) the aroyl ring is disordered over two sets of atomic sites having occupancies of 0.942 (2) and 0.058 (2). In each of (III)–(V), a combination of two C—H⋯π(arene) hydrogen bonds links the mol­ecules into sheets. A single O—H⋯O hydrogen bond links the mol­ecules of 1-(2-hy­droxy­benzo­yl)-4-(4-meth­oxy­phen­yl)Piperazine, C18H20N2O3, (VI), into simple chains. Comparisons are made with the structures of some related compounds.Publisher PDFPeer reviewe

Leigh Ferris - One of the best experts on this subject based on the ideXlab platform.

  • synthesis of enantiopure Piperazines via asymmetric lithiation trapping of n boc Piperazines unexpected role of the electrophile and distal n substituent
    Journal of the American Chemical Society, 2016
    Co-Authors: James D Firth, Peter Obrien, Leigh Ferris
    Abstract:

    A new method for the synthesis of enantiopure α-substituted Piperazines via direct functionalization of the intact Piperazine ring is described. The approach utilizes the asymmetric lithiation–substitution of an α-methylbenzyl-functionalized N-Boc Piperazine using s-BuLi/(−)-sparteine or (+)-sparteine surrogate and provides access to a range of Piperazines (as single stereoisomers). Optimization of the new methodology required a detailed mechanistic study. Surprisingly, it was found that the main culprits affecting the yield and enantioselectivity were the electrophile (the last reagent to be added to the reaction flask) and the distal N-substituent. The mechanistic studies included optimization of lithiation times using in situ IR spectroscopy, identification of a ring-fragmentation of the lithiated Piperazines (that could be minimized with sterically hindered N-alkyl groups), and use of a novel “diamine switch” strategy to improve enantioselectivity with certain electrophiles. The methodology was showca...

  • Synthesis of Enantiopure Piperazines via Asymmetric Lithiation–Trapping of N‑Boc Piperazines: Unexpected Role of the Electrophile and Distal N‑Substituent
    2016
    Co-Authors: James D. Firth, Peter O’brien, Leigh Ferris
    Abstract:

    A new method for the synthesis of enantiopure α-substituted Piperazines via direct functionalization of the intact Piperazine ring is described. The approach utilizes the asymmetric lithiation–substitution of an α-methylbenzyl-functionalized N-Boc Piperazine using s-BuLi/(−)-sparteine or (+)-sparteine surrogate and provides access to a range of Piperazines (as single stereoisomers). Optimization of the new methodology required a detailed mechanistic study. Surprisingly, it was found that the main culprits affecting the yield and enantio­selectivity were the electrophile (the last reagent to be added to the reaction flask) and the distal N-substituent. The mechanistic studies included optimization of lithiation times using in situ IR spectroscopy, identification of a ring-fragmentation of the lithiated Piperazines (that could be minimized with sterically hindered N-alkyl groups), and use of a novel “diamine switch” strategy to improve enantio­selectivity with certain electrophiles. The methodology was showcased with the preparation of an intermediate for Indinavir synthesis and the stereo­selective synthesis of 2,5-trans- and 2,6-trans-Piperazines

Stefano Manfredini - One of the best experts on this subject based on the ideXlab platform.

Krzysztof Walczyński - One of the best experts on this subject based on the ideXlab platform.

  • Non-imidazole histamine H3 ligands. Part III. New 4-n-propylPiperazines as non-imidazole histamine H3-antagonists.
    European journal of medicinal chemistry, 2005
    Co-Authors: Krzysztof Walczyński, Obbe P. Zuiderveld, Henk Timmerman
    Abstract:

    In search for a new lead of non-imidazole histamine H3-receptor antagonists, a series of 1[(2-thiazolopyridine)-4-n-propyl]Piperazines, the analogous 1-[(2-oxazolopyridine)-4-npropyl]Piperazines, 1-[(2-benzothiazole)-4-n-propyl]Piperazine and 1-[(2-benzooxazole)4-n-propyl]Piperazine were prepared and in vitro tested as H3-receptor antagonists (the electrically evoked contraction of the guinea-pig jejunum). It appeared that by comparison of homologous pairs the thiazolo derivatives have slightly higher activity than their oxazolo analogues. The most potent compound of these series is the 1-(2-thiazolo[4,5-c]pyridine)-4-n-propylPiperazine (3c) with pA2 = 7.25 (its oxazole analogue (4g) showed pA2 = 6.9). The structure–activity relationships for compounds with various positions of the nitrogen in the benzene ring for the thiazoles compared with oxazoles are discussed. © 2004 Elsevier SAS. All rights reserved.